BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Isaguliants M, Bayurova E, Avdoshina D, Kondrashova A, Chiodi F, Palefsky JM. Oncogenic Effects of HIV-1 Proteins, Mechanisms Behind. Cancers (Basel) 2021;13:305. [PMID: 33467638 DOI: 10.3390/cancers13020305] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Mulherkar TH, Gómez DJ, Sandel G, Jain P. Co-Infection and Cancer: Host–Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses. Viruses 2022;14:2037. [DOI: 10.3390/v14092037] [Reference Citation Analysis]
2 Feng Y, Wang Z, Zeng D, Song S, Yang Y, Wang A, Xu J, Guo W, Wu M, Shi Y, Zheng Y, Li D, Zhang R, Lu H. High expression of HIV-1 matrix protein p17 in both lymphoma and lymph node tissues of AIDS patients. Pathol Res Pract 2022;237:154061. [PMID: 35939971 DOI: 10.1016/j.prp.2022.154061] [Reference Citation Analysis]
3 Caccuri F, Messali S, Zani A, Campisi G, Giovanetti M, Zanussi S, Vaccher E, Fabris S, Bugatti A, Focà E, Castelli F, Ciccozzi M, Dolcetti R, Gallo RC, Caruso A. HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide. Proc Natl Acad Sci U S A 2022;119:e2122050119. [PMID: 35763571 DOI: 10.1073/pnas.2122050119] [Reference Citation Analysis]
4 Makgoo L, Mosebi S, Mbita Z. Long noncoding RNAs (lncRNAs) in HIV-mediated carcinogenesis: Role in cell homeostasis, cell survival processes and drug resistance. Non-coding RNA Research 2022. [DOI: 10.1016/j.ncrna.2022.07.003] [Reference Citation Analysis]
5 Goubran H, Stakiw J, Seghatchian J, Ragab G, Burnouf T. SARS-CoV-2 and cancer: The intriguing and informative cross-talk. Transfus Apher Sci 2022;:103488. [PMID: 35753906 DOI: 10.1016/j.transci.2022.103488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Maslennikova A, Mazurov D. Application of CRISPR/Cas Genomic Editing Tools for HIV Therapy: Toward Precise Modifications and Multilevel Protection. Front Cell Infect Microbiol 2022;12:880030. [DOI: 10.3389/fcimb.2022.880030] [Reference Citation Analysis]
7 Proulx J, Ghaly M, Park I, Borgmann K. HIV-1-Mediated Acceleration of Oncovirus-Related Non-AIDS-Defining Cancers. Biomedicines 2022;10:768. [DOI: 10.3390/biomedicines10040768] [Reference Citation Analysis]
8 Yekedüz E, Utkan G, Ürün Y. Key considerations and common adverse events for HIV-positive patients with cancer treated with immune checkpoint inhibitors. Future Oncol 2022. [PMID: 35018793 DOI: 10.2217/fon-2021-1513] [Reference Citation Analysis]
9 Kuznetsova AI, Gromov KB, Kireev DE, Shlykova AV, Lopatukhin AE, Kazennova EV, Lebedev AV, Tumanov AS, Kim KV, Bobkova MR. [Analysis of Tat protein characteristics in human immunodeficiency virus type 1 sub-subtype A6 (Retroviridae: Orthoretrovirinae: Lentivirus: Human immunodeficiency virus-1)]. Vopr Virusol 2022;66:452-64. [PMID: 35019252 DOI: 10.36233/0507-4088-83] [Reference Citation Analysis]
10 Rodríguez M, Cristóbal I. Advances in the Knowledge of the Molecular Pathogenesis of High-Prevalence Tumors and Its Relevance for Their Future Clinical Management. Cancers (Basel) 2021;13:6053. [PMID: 34885163 DOI: 10.3390/cancers13236053] [Reference Citation Analysis]
11 Kellogg C, Kouznetsova VL, Tsigelny IF. Implications of viral infection in cancer development. Biochim Biophys Acta Rev Cancer 2021;1876:188622. [PMID: 34478803 DOI: 10.1016/j.bbcan.2021.188622] [Reference Citation Analysis]
12 Ramorola BR, Goolam-Hoosen T, Alves de Souza Rios L, Mowla S. Modulation of Cellular MicroRNA by HIV-1 in Burkitt Lymphoma Cells-A Pathway to Promoting Oncogenesis. Genes (Basel) 2021;12:1302. [PMID: 34573283 DOI: 10.3390/genes12091302] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Bugatti A, Caccuri F, Filippini F, Ravelli C, Caruso A. Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants. J Biol Chem 2021;297:100934. [PMID: 34273353 DOI: 10.1016/j.jbc.2021.100934] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Isaguliants M, Nosik M, Karlsen A, Petrakova N, Enaeva M, Lebedeva N, Podchufarova D, Laga V, Gromov K, Nazarov A, Chowdhury S, Sinitsyn M, Sobkin A, Chistyakova N, Aleshina S, Grabarnik A, Palefsky JM. Prevalence and Risk Factors of Infection with High Risk Human Papilloma Viruses among HIV-Positive Women with Clinical Manifestations of Tuberculosis in a Middle-Income Country. Biomedicines 2021;9:683. [PMID: 34208764 DOI: 10.3390/biomedicines9060683] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Isaguliants M, Krotova O, Petkov S, Jansons J, Bayurova E, Mezale D, Fridrihsone I, Kilpelainen A, Podschwadt P, Agapkina Y, Smirnova O, Kostic L, Saleem M, Latyshev O, Eliseeva O, Malkova A, Gorodnicheva T, Wahren B, Gordeychuk I, Starodubova E, Latanova A. Cellular Immune Response Induced by DNA Immunization of Mice with Drug Resistant Integrases of HIV-1 Clade A Offers Partial Protection against Growth and Metastatic Activity of Integrase-Expressing Adenocarcinoma Cells. Microorganisms 2021;9:1219. [PMID: 34199989 DOI: 10.3390/microorganisms9061219] [Reference Citation Analysis]